Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis

  • Dusan Djokovic1, 2,
  • Alexandre Trindade1, 2,
  • Joana Gigante1, 2,
  • Marina Badenes1, 2,
  • Lilliana Silva1, 2,
  • Ren Liu3,
  • Xiuqing Li3,
  • Ming Gong3,
  • Valery Krasnoperov5,
  • Parkash S Gill3, 4Email author and
  • Antonio Duarte1, 2
BMC Cancer201010:641

DOI: 10.1186/1471-2407-10-641

Received: 9 July 2010

Accepted: 23 November 2010

Published: 23 November 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Jul 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Aug 2010 Reviewed Reviewer Report - Richard Sainson
7 Sep 2010 Reviewed Reviewer Report - Andreas Fischer
1 Oct 2010 Author responded Author comments - Ren Liu
Resubmission - Version 3
1 Oct 2010 Submitted Manuscript version 3
28 Oct 2010 Author responded Author comments - Ren Liu
Resubmission - Version 4
28 Oct 2010 Submitted Manuscript version 4
Publishing
23 Nov 2010 Editorially accepted
23 Nov 2010 Article published 10.1186/1471-2407-10-641

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Centro Interdisciplinar de Investigação em Sanidade Animal (CIISA), Lisbon Technical University
(2)
Instituto Gulbenkian de Ciência
(3)
Department of Pathology, University of Southern California
(4)
Department of Medicine, University of Southern California
(5)
Vasgene Therapeutics

Advertisement